Morgan Stanley
EVHC.PR

Morgan Stanley’s Envision Healthcare Corporation EVHC.PR Stock Holding History

Morgan Stanley’s Portfolio EVHC.PR Stock Details EVHC.PR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-75
Closed -$9K – 6688
2016
Q4 		$9K Buy
+75
New +$9.44K ﹤0.01% 6187

Other funds holding EVHC.PR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Morgan Stanley's EVHC.PR Position: Q1 2017 in Review

Morgan Stanley sold out of Envision Healthcare Corporation (EVHC.PR) in Q1 2017, closing a stake of 75 shares — an estimated $9K sold.

Morgan Stanley first reported a position in EVHC.PR in Q4 2016 and held it in 1 quarter. The position peaked at $9K in Q4 2016. 18 funds tracked by Wall St. Rank hold EVHC.PR as of Q1 2017.

  • Morgan Stanley reported no remaining Envision Healthcare Corporation position as of Q1 2017 after selling out during the quarter.
  • Morgan Stanley sold 75 Envision Healthcare Corporation shares in Q1 2017, an estimated $9K.
  • Morgan Stanley first reported a position in Envision Healthcare Corporation in Q4 2016 and held it in 1 quarter.
  • Morgan Stanley's Envision Healthcare Corporation position peaked at $9K in Q4 2016.
  • 18 funds tracked by Wall St. Rank held Envision Healthcare Corporation as of Q1 2017.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.